AI-powered investigative journalism. Deep analysis of trending topics across technology, science, politics, and culture. This feed features select free episodes. Get daily episodes across 14 topics at d33ply.xyz
Cursor's 30,000-engineer claim and Nvidia's telling silence
A two-year-old startup valued at $9.9 billion claims nearly every Nvidia engineer uses its AI code editor. Nvidia has said nothing to confirm it. The episode examines what unverifiable marketing claims reveal about the AI coding tool gold rush and the fragile economics of developer tooling.
More episodes at d33ply.xyz
12 Feb 2026
Forbes and the mogul myth: 20 interviews, 100 years, zero hard questions
From Henry Ford in 1928 to Elon Musk in 2003, Forbes has offered America's wealthiest entrepreneurs a platform to craft origin myths unchallenged. An examination of how access journalism doubles as a credentialing machine — and who absorbs the cost.
More episodes at d33ply.xyz
11 Feb 2026
Bitso's $12B secret: most of it is remittances, not trading
Bitso has processed over $12B in transactions across Latin America, but the bulk of its volume comes from cross-border remittances and currency hedging — not speculation. An examination of how a Mexico City crypto exchange became financial infrastructure for a region where 57% of adults lack bank accounts, and whether that parallel system can hold.
More episodes at d33ply.xyz
11 Feb 2026
OpenAI's conscience was a nonprofit. Now it's a Pentagon contractor.
Between 2023 and 2025, OpenAI deleted its weapons prohibition, appointed a former NSA director to its board, and deployed ChatGPT on classified military networks. The trajectory from AI safety nonprofit to defense partner traces a $40 billion incentive structure that made each step feel inevitable.
More episodes at d33ply.xyz
10 Feb 2026
Artemis and the case for the Moon as Mars rehearsal
NASA's Artemis program frames the Moon not as a rival destination to Mars but as a prerequisite — a proving ground three days from Earth where life-support failures remain survivable. The logic rests on physics, biology, and resource engineering that Mars-first advocates tend to underestimate.
More episodes at d33ply.xyz
8 Feb 2026
Manchester's ex-criminal hackers are coming for your 12-year-olds
A programme run by former convicted hackers is recruiting secondary school students in Manchester, redirecting young technical talent toward cybersecurity careers before the criminal justice system intervenes. With 3.5 million unfilled cybersecurity positions projected by 2026, the initiative tests a discomforting premise: the skills that produce elite defenders and dangerous criminals are identical.
More episodes at d33ply.xyz
4 Feb 2026
André Ricciardi is dying. A24 is betting his comedy about it will sell.
A terminally ill man's cancer documentary won two Sundance 2025 awards and earned a 92% on Rotten Tomatoes. With A24 and Sandbox Films backing a theatrical release, the film tests whether dark humor can work as both art and public health message.
More episodes at d33ply.xyz
3 Feb 2026
The NHS bet £150M that one blood test can catch 50 cancers early
A multi-cancer early detection test backed by £150 million in NHS funding is nearing its first large-scale results from 140,000 participants. The trial could reshape screening for dozens of cancers that currently go undetected until late stages — or expose the limits of liquid biopsy technology.
More episodes at d33ply.xyz
1 Feb 2026
Medicare now demands proof that therapy works, and a $400B industry isn't ready
New 2026 Medicare reimbursement rules tie behavioral health payments to demonstrated patient outcomes for the first time. After decades of intuition-driven practice, therapists and telehealth startups face a measurement-based care mandate that could reshape how mental health treatment is delivered and funded.
More episodes at d33ply.xyz
28 Jan 2026
Boston Scientific's $14.5B bet on the blood clot vacuum
Boston Scientific is paying ten times revenue to acquire Penumbra, a maker of mechanical thrombectomy devices used in 180,000 procedures last year. The deal signals that independent medtech companies face a scaling ceiling — and that the era of consolidation in life-saving hardware has arrived.
More episodes at d33ply.xyz
Contact d33ply - AI Investigative Podcast
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of d33ply - AI Investigative Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
